Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Reuven, Viskoper"'
Publikováno v:
In American Journal of Hypertension 2003 16(9):734-738
Autor:
Chaim, Yosefy, Noa, Oliel, Aviva, Grosbirt, Doron, Levy, Dov, Gavish, Dror, Dicker, Reuven, Viskoper
Publikováno v:
Harefuah. 155(8)
Atherosclerosis is the main cause of cardiovascular (CV) morbidity and mortality in the western world. Detection and treatment of risk factors (such as hypertension, dyslipidemia and diabetes mellitus) reduce CV events. We have shown cost utility in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc3e3150996dbdb4e71e698a9e47f393
https://pubmed.ncbi.nlm.nih.gov/28530333
https://pubmed.ncbi.nlm.nih.gov/28530333
Autor:
Yosefy, C., Reuven Viskoper, J., Laszt, A., Priluk, R., Guita, E., Varon, D., Illan, Z., Berry, E.M., Savion, N., Adan, Y., Lugassy, G., Schneider, R., Raz, A.
Publikováno v:
In Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) August 1999 61(2):83-87
Autor:
Sverre E. Kjeldsen, Gordon T. Mcinnes, Giuseppe Mancia, Tsushung A. Hua, Stevo Julius, Michael A. Weber, Antonio Coca, Xavier Girerd, Kenneth Jamerson, Pierre Larochelle, Thomas Macdonald, Roland E. Schmieder, M. Anthony Schork, Reuven Viskoper, Jiri Widimský, Alberto Zanchetti, null FOR THE VALUE TRIAL INVESTIGATORS
Publikováno v:
Blood Pressure. 17:170-177
We have previously shown that the angiotensin receptor blocker valsartan is associated with a lower incidence of new-onset type 2 diabetes than that with the calcium-channel antagonist amlodipine in the treatment of hypertensive patients at high card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7528309dd9a9cc76bba93c2dbf55e191
https://doi.org/10.1080/08037050802169644
https://doi.org/10.1080/08037050802169644
Publikováno v:
Hypertension. 36:454-460
Abstract —This multicenter study evaluated the efficacy of candesartan cilexetil, an angiotensin II type 1 receptor antagonist, used alone or in combination with amlodipine or in combination with amlodipine and hydrochlorothiazide in the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de54ae9327fe0b06ce8648d5e45fea0b
https://doi.org/10.1161/01.hyp.36.3.454
https://doi.org/10.1161/01.hyp.36.3.454
Publikováno v:
The American Journal of Cardiology. 80:27C-33C
This paper summarizes the results of 4 double-blind studies of antihypertensive therapy in which mibefradil was compared with other commonly used calcium antagonists (diltiazem CD, amlodipine, nifedipine SR, and nifedipine GITS) at the recommended do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::312fbb62de1ba6a7d378fdc9b7fc5b46
https://doi.org/10.1016/s0002-9149(97)00567-5
https://doi.org/10.1016/s0002-9149(97)00567-5
Publikováno v:
American Journal of Hypertension. 6:349-356
Ro 42-5892 (Ro) is a new renin inhibitor that has been shown to be an orally effective compound in primates and in the first exploratory studies in humans. However, no firm conclusions could be drawn from the human trials and therefore the present st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad0698202d98bcaea13ea55f52e5d011
https://doi.org/10.1093/ajh/6.5.349
https://doi.org/10.1093/ajh/6.5.349
Autor:
Thomas M. MacDonald, Steffan Ekman, Antonio Coca, Sverre E. Kjeldsen, Xavier Girerd, M. Anthony Schork, Reuven Viskoper, Alberto Zanchetti, Kenneth Jamerson, Stevo Julius, Pierre Larochelle, Roland E. Schmieder, Michael A. Weber, Giuseppe Mancia, Pelle Stolt, Tsushung Hua, Jiri Widimský, Gordon T. McInnes
Publikováno v:
Journal of hypertension. 24(7)
Type 2 diabetes is emerging as a major health problem, which tends to cluster with hypertension in individuals at high risk of cardiovascular disease.To test for the first time the hypothesis that treatment of hypertensive patients at high cardiovasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08698423ceb04e595ebdb163533239b7
https://pubmed.ncbi.nlm.nih.gov/16794491
https://pubmed.ncbi.nlm.nih.gov/16794491
Autor:
Eli, Magen, Reuven, Viskoper, Joseph, Mishal, Rita, Priluk, Arkadi, Berezovsky, Anni, Laszt, Daniel, London, Chaim, Yosefy
Publikováno v:
The Israel Medical Association journal : IMAJ. 6(12)
Hypertension is considered resistant if blood pressure cannot be reduced to140/90 mmHg with an appropriate triple-drug regimen, including an oral diuretic, with all agents administered at maximal dosages. This definition has evolved with the developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef4195a3092567b184922952ca1c1f25
https://pubmed.ncbi.nlm.nih.gov/15609886
https://pubmed.ncbi.nlm.nih.gov/15609886
Autor:
Anny Laszt, Ariela Alter, Irena Shapira, Larissa Chornia, Rina Mindlin, Reuven Viskoper, Dror Dicker, Benjamin Gavish, Rita Priluck
Publikováno v:
American journal of hypertension. 16(6)
Recent studies have demonstrated the antihypertensive effect of slow breathing exercises, guided interactively by a device, in patients with uncontrolled blood pressure (BP) without changing medication. This study examined the response to the same tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518788027839a3262e204f173866841c
https://pubmed.ncbi.nlm.nih.gov/12799098
https://pubmed.ncbi.nlm.nih.gov/12799098